Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
74 results
  1. MedlinePlus Drug Information: Melphalan Injection 
    https://medlineplus.gov/druginfo/meds/a612019.html
    Melphalan injection is used to treat multiple myeloma (a type of cancer of the bone marrow) in people who are unable to take melphalan by mouth. Melphalan injection is also used to ...
  2. MedlinePlus Drug Information: Melphalan 
    https://medlineplus.gov/druginfo/meds/a682220.html
    Melphalan is used to treat multiple myeloma (a type of cancer of the bone marrow). Melphalan is also used to treat a certain type ... the female reproductive organs where eggs are formed). Melphalan is in a class of medications called alkylating ...
  3. MedlinePlus Drug Information: Melphalan Flufenamide Injection 
    https://medlineplus.gov/druginfo/meds/a621032.html
    Melphalan flufenamide injection is used along with dexamethasone to treat multiple myeloma (a type of cancer of ... after receiving at least four other chemotherapy medications. Melphalan flufenamide is in a class of medications called ...
  4. Ewing Sarcoma and Undifferentiated Small Round Cell Sarcomas of Bone and Soft Tissue Treatment (PDQ®) - PDQ Cancer ... 
    https://www.ncbi.nlm.nih.gov/books/NBK66045
    ... and whole-lung radiation therapy; P = .21).[ 25 ] Melphalan. At nonmyeloablative doses, melphalan proved to be an ...
  5. Neuroblastoma Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65747
    ... use tandem chemotherapy and HSCT with carboplatin/etoposide/melphalan or busulfan/melphalan as conditioning for HSCT.[ 27 ][ Level of evidence ... achieved an adequate response to receive either busulfan/melphalan or carboplatin/etoposide/melphalan.[ 28 ][ Level of evidence ...
  6. Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65924
    ... Zhang W, Jiao L, et al.: Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS ... first-line treatment for POEMS syndrome: autologous transplantation, melphalan and dexamethasone, or lenalidomide and dexamethasone? Leukemia 33 ( ...
  7. Retinoblastoma Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK66006
    ... consolidated with local control measures, as described above. Melphalan is the most common and most effective agent ... systemic chemotherapy followed by consolidation with intra-arterial melphalan.[ 24 ] Ocular salvage rates when intra-arterial chemotherapy ...
  8. Complications, Graft-Versus-Host Disease, and Late Effects After Pediatric Hematopoietic Stem Cell Transplant (PDQ®) - .... 
    https://www.ncbi.nlm.nih.gov/books/NBK577669
    ... compared myeloablative busulfan/cyclophosphamide with reduced-intensity fludarabine/melphalan.[ 133 ][ Level of evidence C1 ] Spontaneous puberty occurred ...
  9. Intravenous Vitamin C (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK121338
    ... arsenic trioxide and ascorbic acid to high-dose melphalan was reported safe and well tolerated Melphalan 1iiDii [ 19 ] Phase II , open label Relapsed or ... multiple myeloma 1,000 mg 65; 65; none Melphalan, arsenic trioxide, and ascorbic acid was effective and ...
  10. Late Effects of Treatment for Childhood Cancer (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK65832
    ... pCT and AML-pCT include cyclophosphamide, ifosfamide, mechlorethamine, melphalan, busulfan, nitrosoureas, chlorambucil, and dacarbazine.[ 20 ] The risk ...
first · previous · 1 · 2 · 3 · 4 · 5 · 6 · next · last